Free Trial
NASDAQ:SXTPW

60 Degrees Pharmaceuticals (SXTPW) Stock Price, News & Analysis

$0.02 0.00 (-0.87%)
As of 04/1/2025 12:19 PM Eastern

About 60 Degrees Pharmaceuticals Stock (NASDAQ:SXTPW)

Key Stats

Today's Range
$0.02
$0.02
50-Day Range
$0.02
$0.04
52-Week Range
$0.01
$0.13
Volume
4,100 shs
Average Volume
21,793 shs
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

60 Degrees Pharmaceuticals, Inc. operates as a specialty pharmaceutical company that engages in the development and commercialization of therapies for the prevention and treatment of infectious diseases. The company offers Arakoda for malaria preventative treatment. It also engages in the development of Tafenoquine (Arakoda regimen) that is in Phase IIb clinical trial for COVID-19; Tafenoquine for fungal lung infections, tick-borne diseases, candidiasis, and other infectious and non-infectious diseases; and Celgosivir for respiratory viruses and dengue. The company was founded in 2010 and is based in Washington, District of Columbia.

Remove Ads
Receive SXTPW Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for 60 Degrees Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter.

SXTPW Stock News Headlines

60 Degrees Pharmaceuticals Inc trading halted, news pending
Elon Musk Confirms: Tesla’s Optimus is Replacing Workers… and Heading to Mars
Musk confirmed that SpaceX's Starship will carry Optimus to Mars in 2026 as part of an autonomous mission to help build human colonies on the Red Planet. And here on Earth? Optimus is about to change everything.
See More Headlines

SXTPW Stock Analysis - Frequently Asked Questions

60 Degrees Pharmaceuticals' stock was trading at $0.0297 at the start of the year. Since then, SXTPW shares have decreased by 23.2% and is now trading at $0.0228.
View the best growth stocks for 2025 here
.

Shares of SXTPW stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Biotechnology
Sub-Industry
N/A
Current Symbol
NASDAQ:SXTPW
Fax
N/A
Employees
2
Year Founded
N/A

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
$502,409.00
Price / Cash Flow
N/A
Price / Book
N/A

Miscellaneous

Free Float
N/A
Optionable
Not Optionable
Beta
N/A
The Best High-Yield Dividend Stocks for 2025 Cover

Discover the 10 Best High-Yield Dividend Stocks for 2025 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.

Get This Free Report

This page (NASDAQ:SXTPW) was last updated on 4/3/2025 by MarketBeat.com Staff
From Our Partners